Skip to main content

Lampit Side Effects

Generic name: nifurtimox

Medically reviewed by Drugs.com. Last updated on Sep 21, 2023.

Note: This document contains side effect information about nifurtimox. Some dosage forms listed on this page may not apply to the brand name Lampit.

Applies to nifurtimox: oral tablet.

Serious side effects of Lampit

Along with its needed effects, nifurtimox (the active ingredient contained in Lampit) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking nifurtimox:

More common

Less common

Rare

Incidence not known

Other side effects of Lampit

Some side effects of nifurtimox may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Rare

For Healthcare Professionals

Applies to nifurtimox: oral tablet.

General

The side effects reported most often in patients treated with this drug for 60 days were vomiting, abdominal pain, headache, decreased appetite, nausea, pyrexia, and rash.[Ref]

Gastrointestinal

Very common (10% or more): Vomiting (14.6%), abdominal pain (included abdominal pain, upper abdominal pain; 13.2%)

Common (1% to 10%): Nausea, diarrhea[Ref]

Nervous system

Very common (10% or more): Headache (12.8%)

Common (1% to 10%): Dizziness

Uncommon (0.1% to 1%): Vertigo, paresthesia, tremor, somnolence, seizure, syncope

Postmarketing reports: Vertigo, amnesia, polyneuropathy[Ref]

Metabolic

Very common (10% or more): Decreased appetite (10.5%)[Ref]

Other

Common (1% to 10%): Pyrexia, weight decreased

Uncommon (0.1% to 1%): Asthenia, fatigue[Ref]

Dermatologic

Common (1% to 10%): Rash (included rash, macular rash, maculopapular rash, morbilliform rash, papular rash), urticaria

Uncommon (0.1% to 1%): Pruritus

Postmarketing reports: Angioedema, drug reaction with eosinophilia and systemic symptoms (DRESS)[Ref]

Hematologic

Common (1% to 10%): Anemia, eosinophilia

Uncommon (0.1% to 1%): Neutropenia, leukopenia

Postmarketing reports: Thrombocytopenia[Ref]

Psychiatric

Uncommon (0.1% to 1%): Irritability, anxiety

Postmarketing reports: Apathy, agitation, psychotic behavior, sleep disorder[Ref]

Musculoskeletal

Uncommon (0.1% to 1%): Arthralgia, myalgia

Postmarketing reports: Muscle weakness[Ref]

Hypersensitivity

Postmarketing reports: Hypersensitivity reactions (including anaphylaxis)[Ref]

References

1. Product Information. Lampit (nifurtimox). Bayer Pharmaceutical Inc. 2020.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.